William Blair & Company
DMTK

William Blair & Company’s DermTech, Inc. Common Stock DMTK Stock Holding History

William Blair & Company’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33,717
Closed -$134K – 1883
2022
Q3 		$134K Sell
33,717
-140
-0.4% -$861 ﹤0.01% 1461
2022
Q2 		$188K Buy
33,857
+3,251
+11% +$26.6K ﹤0.01% 1441
2022
Q1 		$449K Sell
30,606
-924
-3% -$12.4K ﹤0.01% 1201
2021
Q4 		$498K Sell
31,530
-52,594
-63% -$1.26M ﹤0.01% 1215
2021
Q3 		$2.7M Buy
84,124
+39,394
+88% +$1.38M 0.01% 620
2021
Q2 		$1.86M Buy
44,730
+500
+1% +$20.5K 0.01% 728
2021
Q1 		$2.25M Sell
44,230
-18,950
-30% -$991K 0.01% 658
2020
Q4 		$2.05M Buy
+63,180
New +$896K 0.01% 644

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair & Company's DMTK Position: Q4 2022 in Review

William Blair & Company sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 33,717 shares — an estimated $134K sold.

William Blair & Company first reported a position in DMTK in Q4 2020 and held it in 8 quarters. The position peaked at $2.7M in Q3 2021. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

  • William Blair & Company reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • William Blair & Company sold 33,717 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $134K.
  • William Blair & Company first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • William Blair & Company's DermTech, Inc. Common Stock position peaked at $2.7M in Q3 2021.
  • 94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on William Blair & Company's 13F filing for Q4 2022, filed 10 Feb 2023.